Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

27.8%

5 terminated/withdrawn out of 18 trials

Success Rate

70.6%

-15.9% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

0 of 12 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

12(70.6%)

Phase 1

3(17.6%)

Early Phase 1

1(5.9%)

Phase 4

1(5.9%)

17Total

Phase 2(12)

Phase 1(3)

Early Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials

NCT02192151Terminated

Study of PHN131 in Healthy Volunteers

Role: lead

NCT02193620Phase 2Completed

Study of PHN131 in Patients After Surgery

Role: lead

NCT05440227Phase 2Recruiting

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Role: lead

NCT01068041Phase 2Completed

Effects of PH3 in Diabetic Nephropathy

Role: lead

NCT03611712Phase 2Completed

PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

Role: lead

NCT03314805Phase 2Completed

PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy

Role: lead

NCT02077621Phase 2Withdrawn

Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

Role: lead

NCT00523107Phase 2Completed

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Role: lead

NCT01720550Phase 4Completed

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Role: lead

NCT01720563Phase 2Terminated

A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy

Role: lead

NCT00518869Phase 2Terminated

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Role: lead

NCT01696565Phase 1Completed

PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy

Role: lead

NCT00861549Phase 1Completed

Bioavailability, Pharmacokinetics and Safety Evaluation of Phencynonate Hydrochloride in Healthy Volunteers

Role: lead

NCT01325233Early Phase 1Completed

The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke

Role: lead

NCT00860600Phase 2Completed

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Role: lead

NCT00693667Phase 2Completed

Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women

Role: lead

NCT01052090Phase 1Terminated

Safety and Efficacy Study in Hepatitis C Patients With PHN121

Role: lead

NCT00547846Phase 2Completed

A Phase II Clinical Study of PDC-748 in Patients With Acute Cough

Role: lead

All 18 trials loaded